4 Results for "

SARS-CoV-2-IN-30

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "SARS-CoV-2-IN-30" in MCE Product Catalog:

Cat. No.: HY-151278
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV-2-IN-30 is a two-armed diphosphate ester with benzene system and molecular tweezers. SARS-CoV-2-IN-30 exhibits antiviral activity with IC50s of 0.6 μM and 6.9 μM against SARS-CoV-2 activity and the spike pseudoparticle transduction, respectively. SARS-CoV-2-IN-30 induces liposomal membrane disruption with an EC50 value of 6.9 μM .
loading...
    loading...
Cat. No.: HY-151278A
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV-2-IN-30 disodium is a two-armed diphosphate ester with benzene system and molecular tweezers. SARS-CoV-2-IN-30 disodium exhibits antiviral activity with IC50s of 0.6 μM and 6.9 μM against SARS-CoV-2 activity and the spike pseudoparticle transduction, respectively. SARS-CoV-2-IN-30 disodium induces liposomal membrane disruption with an EC50 value of 6.9 μM .
loading...
    loading...
Cat. No.: HY-159932
CAS No.: 3107600-77-8
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV-2 Mpro-IN-30 (compound L2) is a SARS-CoV-2 Mpro with the IC50 of 9.1 nM .
loading...
    loading...
Cat. No.: HY-183185
CAS No.: 3028405-31-1
Target:  

SARS-CoV

Research Areas:  

Infection

BZ-30 is an orally active broad-spectrum SARS-CoV-2 inhibitor. BZ-30 acts on the early stage of the viral life cycle, can partially inhibit the endosomal entry process and reduce viral replication levels. BZ-30 reduces viral load, improves pulmonary pathological conditions, and decreases the lung-to-body weight ratio in hamster models challenged with SARS-CoV-2. BZ-30 can be used for research related to COVID-19 .
loading...
    loading...